小艾飞蜜膏乙醇提取物及其活性成分胡椒碱对胃癌的作用和机制研究

    Study on the Effect and Mechanism of the Ethanol Extract of Xiao-ai-fei Honey Ointment and It’s Active Component Piperine on Gastric Cancer

    • 摘要:
      目的 研究小艾飞蜜膏乙醇提取物(ethanol extract of Xiao-ai-fei honey ointment,EXHO)及其活性成分胡椒碱对胃癌的作用和机制。
      方法 使用小鼠胃癌MFC细胞建立ICR小鼠皮下荷瘤模型,成模后给予不同剂量EXHO,连续给药14 d,计算抑瘤率;利用溶剂萃取法获得EXHO不同极性部位,MTT法对其进行活性筛选;GC-MS法对活性最佳的EXHO石油醚部位进行成分分析;利用网络药理学方法进行活性成分与作用靶点预测;再次采用MFC细胞建立ICR小鼠皮下荷瘤模型,胡椒碱不同剂量连续给药14 d,计算抑瘤率;HE染色观察各组小鼠的主要脏器组织病理学变化,免疫组化法观察肿瘤组织中增殖细胞核抗原(proliferating cell nuclear antigen,PCNA)、血管内皮生长因子(vascular endothelial growth factor,VEGF)表达;CCK-8法检测胡椒碱对BGC-823细胞增殖的影响;ELISA检测细胞凋亡酶活性;Western blotting检测细胞凋亡和细胞周期蛋白表达。
      结果 与模型组相比,EXHO低、中、高剂量组瘤重显著降低(P<0.01)。与空白对照组相比,EXHO石油醚萃取部位对BGC-823细胞抑制作用最强;石油醚萃取部位GC-MS分析共检测出23个化合物,经化合物靶点预测筛选出作用最佳单体化合物胡椒碱。与模型组相比,胡椒碱低、中、高剂量组瘤重显著降低(P<0.01);组织病理学结果显示,胡椒碱高剂量组小鼠肺部出现轻微病理变化;与模型组相比,胡椒碱中、高剂量组动物肿瘤组织中PCNA、VEGF表达明显降低(P<0.01)。胡椒碱各剂量组均能抑制BGC-823细胞增殖,与空白对照组相比,胡椒碱各浓度下处理的BGC-823细胞内半胱天冬酶-3(cysteine-dependent aspartate-specific protease-3,Caspase-3)、Caspase-8、Caspase-9酶活性均显著增加;Caspase-3、Caspase-8、Caspase-9、Bcl-2相关X蛋白(Bcl-2-associated X protein,Bax)表达显著升高,信号转导和转录激活因子3(signal transducer and activator of transcription 3,STAT3)、细胞周期蛋白B1(CyclinB1)、细胞周期蛋白D1(CyclinD1)、B细胞淋巴瘤-2(B-cell lymphoma,Bcl-2)表达显著降低(P<0.05或P<0.01)。
      结论 EXHO及其单体成分胡椒碱能抑制MFC胃癌小鼠肿瘤生长,其机制可能与抑制肿瘤细胞增殖,调节Caspase、Bax/Bcl-2信号通路和细胞周期蛋白CyclinB1、CyclinD1的表达有关。

       

      Abstract:
      OBJECTIVE To investigate the effect and mechanism of the ethanol extract of Xiao-ai-fei honey ointment(EXHO) and it’s active component piperine on gastric cancer.
      METHODS The subcutaneous tumor bearing model of ICR mice was established by using mouse gastric cancer MFC cells. After the model was established, different doses of EXHO were given for 14 days, and the tumor inhibition rate was calculated. EXHO was sequentially partitioned to yield different fractions; activity-guided screening was performed by MTT assay. The most potent petroleum-ether fraction was analyzed by GC-MS, and network pharmacology was employed to predict active compounds and their targets. Then MFC cells were used to establish the subcutaneous tumor bearing model of ICR mice. Piperine was administered at different doses for 14 days, and the tumor inhibition rate was calculated. HE staining was used to observe histopathological changes in the major organs of mice in each group, while proliferating cell nuclear antigen(PCNA) and vascular endothelial growth factor(VEGF) expression in tumors was evaluated immunohistochemically. CCK-8 assay measured piperine-induced growth inhibition of BGC-823 cells; caspase activities were quantified by ELISA and apoptosis- and cell-cycle-related proteins were analyzed by Western blotting.
      RESULTS Compared with the model group, tumor weight was markedly reduced in EXHO low-, medium- and high-dose groups(P<0.01). Compared with blank control, the petroleum-ether fraction of EXHO exhibited the strongest inhibition on BGC-823 cells. GC-MS identified 23 compounds; target prediction singled out piperine as the most active constituent. Compared with the model group, tumor weight was significantly reduced in the piperine low-, medium-, and high-dose groups(P<0.05 or P<0.01). Histopathology showed pulmonary changes in the high-dose piperine group. Immunohistochemistry revealed pronounced down-regulation of PCNA and VEGF in tumors from the medium- and high-dose piperine groups(P<0.01). Piperine could inhibit the proliferation of BGC-823 cells, compared with the blank control group, the activities of cysteine-dependent aspartate-specific protease-3(Caspase-3), Caspase-8 and Caspase-9 in BGC-823 cells treated with piperine at different concentrations were significantly increased; The expressions of Caspase-3, Caspase-8, Caspase-9 and Bcl-2-associated X protein(Bax) were significantly increased, while the expressions of signal transducer and activator of transcription 3(STAT3), CyclinB1, CyclinD1 and B-cell lymphoma(Bcl-2) were significantly decreased(P<0.05 or P<0.01).
      CONCLUSION EXHO and its monomer piperine can inhibit the tumor growth of MFC gastric cancer mice, and its mechanism may be related to inhibiting the proliferation of tumor cells, regulating the expression of Caspase, Bax/Bcl-2 signaling pathway and CyclinB1, CyclinD1.

       

    /

    返回文章
    返回